Velarion Records
Free. Unsubscribe any time.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

TEVA PHARMACEUTICAL INDUSTRIES LTD filed 37 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 57 transactions and 2,704,289 shares. 37 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in TEVA PHARMACEUTICAL INDUSTRIES LTD 57

Adoption dates in TEVA PHARMACEUTICAL INDUSTRIES LTD 9

Results prints in TEVA PHARMACEUTICAL INDUSTRIES LTD 8

Trades before a print in TEVA PHARMACEUTICAL INDUSTRIES LTD 0

Interval to TEVA PHARMACEUTICAL INDUSTRIES LTD’s next reported results date

How the interval and sources are counted →

Adoption dates TEVA PHARMACEUTICAL INDUSTRIES LTD states

Filing text: “10b5-1 trading plan adopted by the reporting person on November 15, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.